Materials and Methods Protocol 1 : Assessment of AT 1 and AT 2 Receptor Expression in the Remnant Kidney

The role of the angiotensin type 2 (AT(2)) receptor in the pathogenesis of progressive renal injury has not been previously elucidated. The renal expression of the AT(1) and AT(2) receptors in subtotally nephrectomized rats (STNx) and the effects of AT(2) receptor blockade on renal injury were explored. Reduced renal expression of the AT(1) but not the AT(2) receptor was observed in STNx by reverse transcription-PCR, by in vitro autoradiography, and by immunohistochemical staining. The STNx rats were randomly assigned to AT(1) receptor antagonist valsartan, AT(2) receptor antagonist PD123319, or the combination of both for 4 wk. Increased proteinuria in STNx rats was reduced by PD123319 but to a lesser degree when compared with valsartan. Reduced gene and protein expression of the slit diaphragm protein nephrin was prevented by either valsartan or PD123319. Expression of osteopontin, proliferating cell nuclear antigen, and monocyte/macrophage infiltration was increased in STNx rats and was reduced by both AT(1) and AT(2) receptor antagonists. These effects of AT(2) receptor antagonism were observed in the presence of increased BP in STNx rats. These findings suggest that blockade of the AT(2) receptor alone confers a degree of renal protection; in particular, it seems that the combination of the AT(1) and AT(2) receptor antagonists may confer additive renal effects than either receptor antagonist as monotherapy.

[1]  I. Narita,et al.  Expression, roles, receptors, and regulation of osteopontin in the kidney. , 2001, Kidney international.

[2]  T. Ichiki,et al.  Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension , 2001, Circulation.

[3]  M. Cooper,et al.  Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension , 2001, Diabetologia.

[4]  M. Cooper,et al.  Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade , 2001, Diabetologia.

[5]  M. Cooper,et al.  Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion , 2001, Journal of hypertension.

[6]  G. Remuzzi,et al.  Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. , 2001, Journal of the American Society of Nephrology : JASN.

[7]  L. Opie,et al.  Enhanced Angiotensin II Activity in Heart Failure: Reevaluation of the Counterregulatory Hypothesis of Receptor Subtypes , 2001, Circulation research.

[8]  L. Daviet,et al.  Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. , 2001, Cardiovascular research.

[9]  H. Sasamura,et al.  EXAMINATION OF ANGIOTENSIN II TYPE 1 AND TYPE 2 RECEPTOR EXPRESSION IN HUMAN KIDNEYS BY IMMUNOHISTOCHEMISTRY , 2001, Clinical and experimental hypertension.

[10]  M. Cooper,et al.  Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. , 2000, Kidney international.

[11]  Y. Ouchi,et al.  Inhibitory Effect of Angiotensin II Type 2 Receptor on Coronary Arterial Remodeling After Aortic Banding in Mice , 2000, Circulation.

[12]  M. Cooper,et al.  Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. , 2000, Kidney international.

[13]  M. Cooper,et al.  Blockade of the Renin-Angiotensin and Endothelin Systems on Progressive Renal Injury , 2000, Hypertension.

[14]  D. Salant,et al.  Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. , 2000, Kidney international.

[15]  D. Salant,et al.  Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. , 1999, The Journal of clinical investigation.

[16]  Y. Mori,et al.  Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. , 1999, The Journal of clinical investigation.

[17]  M. Cooper,et al.  Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. , 1999, Hypertension.

[18]  K. Tryggvason,et al.  Nephrin is specifically located at the slit diaphragm of glomerular podocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Ichiki,et al.  Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. , 1999, Biochemical and biophysical research communications.

[20]  R. Johns,et al.  Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension. , 1999, Hypertension.

[21]  G. Remuzzi,et al.  Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.

[22]  T. Unger,et al.  Angiotensin II Receptors in the Kidney , 1998, Kidney and Blood Pressure Research.

[23]  R. Carey,et al.  Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. , 1998, Hypertension.

[24]  L Peltonen,et al.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. , 1998, Molecular cell.

[25]  E. Schiffrin,et al.  Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats. , 1998, Hypertension.

[26]  R. Atkins,et al.  Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II. , 1997, Kidney international. Supplement.

[27]  R. Carey,et al.  Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. , 1997, Hypertension.

[28]  F. Thaiss,et al.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. , 1997, The Journal of clinical investigation.

[29]  R. Carey,et al.  The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. , 1997, The Journal of clinical investigation.

[30]  The Gisen Group.  Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy , 1997, The Lancet.

[31]  M. Cooper,et al.  Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury , 1997, Diabetologia.

[32]  M. Cooper,et al.  Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system , 1997 .

[33]  Mingyan Zhu,et al.  Functional Interactions Between Neuronal AT1 and AT2 Receptors. , 1997, Endocrinology.

[34]  G. Jerums,et al.  Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. , 1997, The Journal of clinical investigation.

[35]  M. Cooper,et al.  Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. , 1997, Kidney international.

[36]  D. Lu,et al.  Functional interactions between neuronal AT1 and AT2 receptors. , 1997, Endocrinology.

[37]  W A Hsueh,et al.  Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. , 1996, The Journal of clinical investigation.

[38]  T. Hostetter,et al.  Role of aldosterone in the remnant kidney model in the rat. , 1996, The Journal of clinical investigation.

[39]  B. Lévy,et al.  Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. , 1996, The Journal of clinical investigation.

[40]  R. Carey,et al.  The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. , 1996, The Journal of clinical investigation.

[41]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[42]  F. Locatelli,et al.  Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. , 1996, The New England journal of medicine.

[43]  F. Jelínek,et al.  Lack of a beneficial effect of PD123319, an AT2-angiotensin receptor antagonist, on the course of ablation nephropathy in the rat. , 1996, Kidney & blood pressure research.

[44]  R. Morishita,et al.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Klahr,et al.  Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  F. Terzi,et al.  Experimental models of nephron reduction: some answers, many questions. , 1995, Kidney international. Supplement.

[47]  M. Paul,et al.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. , 1995, The Journal of clinical investigation.

[48]  J. Ménard,et al.  Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. , 1994, Kidney international.

[49]  C. Alpers,et al.  Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. , 1994, Kidney international.

[50]  J. Prost,et al.  Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. , 1992, Hypertension.

[51]  T. Meyer,et al.  Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. , 1992, The Journal of clinical investigation.

[52]  G. Jerums,et al.  Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. , 1992, Kidney international.

[53]  M. Schambelan,et al.  Expression of AT2 receptors in the developing rat fetus. , 1991, The Journal of clinical investigation.

[54]  K. Catt,et al.  Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography. , 1987, Kidney international. Supplement.

[55]  B. Brenner,et al.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. , 1985, The Journal of clinical investigation.